🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and how well giving autologous ...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2012-01
Trial ID
NCT01477021
Treatments Being Tested
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
This cancer vaccine research study involves the injection of the NY-ESO-1b ...
Status
Completed
Location
Krankenhaus Nordwest
Start Date
2003-09-03
Trial ID
NCT00199836
Treatments Being Tested
The purpose of this study is assess the safety of administering repeated do...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2011-05
Trial ID
NCT01234012
Treatments Being Tested
The incidence of melanoma is increasing with an estimated incidence of 59,9...
Status
Completed
Location
New York University Langone Medical Center
Start Date
2010-09
Trial ID
NCT01079741
Treatments Being Tested
TCR-T cell therapy experienced a breakthrough for treating tumors in recent...
Status
Unknown
Location
Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University
Start Date
2017-03-21
Trial ID
NCT03029273
Treatments Being Tested
This is an open-label, multicenter, 2-arm study to evaluate the safety and ...
Status
Completed
Location
Research Facility
Start Date
2017-12-20
Trial ID
NCT03164772
Treatments Being Tested
RATIONALE: Vaccines made from peptides may make the body build an immune re...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2003-10-28
Trial ID
NCT00070070
Treatments Being Tested
This phase I/IIa trial studies the side effects and best dose of gene-modif...
Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
Start Date
2017-07-14
Trial ID
NCT02650986
The hope is that the peptide vaccines will stimulate the immune system to a...
Status
Completed
Location
University of Arkansas for Medical Sciences/MIRT
Start Date
2004-06
Trial ID
NCT00090493
Treatments Being Tested